BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14742572)

  • 21. Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines.
    Yang HH; Madoff LC; Guttormsen HK; Liu YD; Paoletti LC
    Infect Immun; 2007 Jul; 75(7):3455-61. PubMed ID: 17470542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conjugate vaccines against group B Streptococcus types IV and VII.
    Paoletti LC; Kasper DL
    J Infect Dis; 2002 Jul; 186(1):123-6. PubMed ID: 12089673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A surface-displayed cholera toxin B peptide improves antibody responses using food-grade staphylococci for mucosal subunit vaccine delivery.
    Cano F; Liljeqvist S; Nguyen TN; Samuelson P; Bonnefoy JY; Ståhl S; Robert A
    FEMS Immunol Med Microbiol; 1999 Aug; 25(3):289-98. PubMed ID: 10459584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal immunization against dental caries with a Streptococcus mutans-enriched fimbrial preparation.
    Fontana M; Dunipace AJ; Stookey GK; Gregory RL
    Clin Diagn Lab Immunol; 1999 May; 6(3):405-9. PubMed ID: 10225844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temperature-Induced Self-Assembly of the Group B Streptococcus (GBS) Fusion Antigen GBS-NN.
    Rose F; Roovers S; Fano M; Harloff-Helleberg S; Kirkensgaard JJK; Hejnaes K; Fischer P; Foged C
    Mol Pharm; 2018 Jul; 15(7):2584-2593. PubMed ID: 29745668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection.
    Larsson C; Lindroth M; Nordin P; Stålhammar-Carlemalm M; Lindahl G; Krantz I
    Arch Dis Child Fetal Neonatal Ed; 2006 Nov; 91(6):F403-8. PubMed ID: 17056838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with the immunodominant Helicobacter suis urease subunit B induces partial protection against H. suis infection in a mouse model.
    Vermoote M; Van Steendam K; Flahou B; Smet A; Pasmans F; Glibert P; Ducatelle R; Deforce D; Haesebrouck F
    Vet Res; 2012 Oct; 43(1):72. PubMed ID: 23101660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Group B streptococcal surface proteins as targets for protective antibodies: identification of two novel proteins in strains of serotype V.
    Areschoug T; Stålhammar-Carlemalm M; Larsson C; Lindahl G
    Infect Immun; 1999 Dec; 67(12):6350-7. PubMed ID: 10569749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant.
    Saito M; Otake S; Ohmura M; Hirasawa M; Takada K; Mega J; Takahashi I; Kiyono H; McGhee JR; Takeda Y; Yamamoto M
    J Infect Dis; 2001 Mar; 183(5):823-6. PubMed ID: 11181162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.
    Russell MW; Moldoveanu Z; White PL; Sibert GJ; Mestecky J; Michalek S M
    Infect Immun; 1996 Apr; 64(4):1272-83. PubMed ID: 8606090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate.
    Paoletti LC; Pinel J; Kennedy RC; Kasper DL
    J Infect Dis; 2000 Feb; 181(2):653-8. PubMed ID: 10669351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections.
    Stålhammar-Carlemalm M; Stenberg L; Lindahl G
    J Exp Med; 1993 Jun; 177(6):1593-603. PubMed ID: 8496678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.
    Hall MA; Stroop SD; Hu MC; Walls MA; Reddish MA; Burt DS; Lowell GH; Dale JB
    Infect Immun; 2004 May; 72(5):2507-12. PubMed ID: 15102757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of recombinant group B streptococcal protein ScaAB and evaluation of its immunogenicity.
    Vorobieva EI; Meringova LF; Leontieva GF; Grabovskaya KB; Suvorov AN
    Folia Microbiol (Praha); 2005; 50(2):172-6. PubMed ID: 16110924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice.
    Pimenta FC; Miyaji EN; Arêas AP; Oliveira ML; de Andrade AL; Ho PL; Hollingshead SK; Leite LC
    Infect Immun; 2006 Aug; 74(8):4939-44. PubMed ID: 16861686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues.
    Toida N; Hajishengallis G; Wu HY; Russell MW
    Infect Immun; 1997 Mar; 65(3):909-15. PubMed ID: 9038296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
    Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
    ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.
    Yamamoto M; McDaniel LS; Kawabata K; Briles DE; Jackson RJ; McGhee JR; Kiyono H
    Infect Immun; 1997 Feb; 65(2):640-4. PubMed ID: 9009325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal immunization with lipoteichoic acid and cholera toxin evokes specific pharyngeal IgA and systemic IgG responses and inhibits streptococcal adherence to pharyngeal epithelial cells in mice.
    Yokoyama Y; Harabuchi Y
    Int J Pediatr Otorhinolaryngol; 2002 May; 63(3):235-41. PubMed ID: 11997159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.